Idiopathic hypersomnia (IH) is a rare sleep disorder marked by an over sleeping duration time during the day even after a longer sleeping hours of night sleep. People with idiopathic hypersomnia sleep normal or for long hours each night but still feel excessively sleepy during the day. Idiopathic hypersomnia is a type of hypersomnia and symptoms include chronic excessive daytime sleepiness (EDS), non-refreshing daytime napping, sleep drunkenness after nighttime sleep, naps, and others. Idiopathic hypersomnia is a nervous system disease, whose cause is not known. There is no single drug available that is approved by the U.S. FDA for this disease, but medicines such as dextroamphetamine that are approved for narcolepsy, one of the types of hypersomnia can be used for idiopathic hypersomnia off-label.

Market Analysis and Insights: Global Idiopathic Hypersomnia Treatment Market

The global Idiopathic Hypersomnia Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Idiopathic Hypersomnia Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Idiopathic Hypersomnia Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Idiopathic Hypersomnia Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Idiopathic Hypersomnia Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Idiopathic Hypersomnia Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Idiopathic Hypersomnia Treatment revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Idiopathic Hypersomnia Treatment Market Report

Report Metric	Details
Report Name	Idiopathic Hypersomnia Treatment Market
CAGR	5%
Segment by Type	Stimulant Medications Non-Stimulant Wake-Promoting Medications Sodium Oxybate
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Takeda Pharmaceutical, Teva Pharmaceutical Industries, Jazz Pharmaceuticals, BIOPROJET, Avadel Pharmaceuticals, GlaxoSmithKline, Pfizer, Theranexus, Fisher and Paykel Healthcare, Drive DeVilbiss Healthcare, Merck
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Idiopathic Hypersomnia Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Idiopathic Hypersomnia Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Idiopathic Hypersomnia Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Idiopathic Hypersomnia Treatment Market report?

Ans: The main players in the Idiopathic Hypersomnia Treatment Market are Takeda Pharmaceutical, Teva Pharmaceutical Industries, Jazz Pharmaceuticals, BIOPROJET, Avadel Pharmaceuticals, GlaxoSmithKline, Pfizer, Theranexus, Fisher and Paykel Healthcare, Drive DeVilbiss Healthcare, Merck

What are the Application segmentation covered in the Idiopathic Hypersomnia Treatment Market report?

Ans: The Applications covered in the Idiopathic Hypersomnia Treatment Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Idiopathic Hypersomnia Treatment Market report?

Ans: The Types covered in the Idiopathic Hypersomnia Treatment Market report are Stimulant Medications, Non-Stimulant Wake-Promoting Medications, Sodium Oxybate

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Idiopathic Hypersomnia Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Stimulant Medications

1.2.3 Non-Stimulant Wake-Promoting Medications

1.2.4 Sodium Oxybate

1.3 Market by Application

1.3.1 Global Idiopathic Hypersomnia Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Idiopathic Hypersomnia Treatment Market Perspective (2019-2030)

2.2 Global Idiopathic Hypersomnia Treatment Growth Trends by Region

2.2.1 Idiopathic Hypersomnia Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Idiopathic Hypersomnia Treatment Historic Market Size by Region (2019-2024)

2.2.3 Idiopathic Hypersomnia Treatment Forecasted Market Size by Region (2025-2030)

2.3 Idiopathic Hypersomnia Treatment Market Dynamics

2.3.1 Idiopathic Hypersomnia Treatment Industry Trends

2.3.2 Idiopathic Hypersomnia Treatment Market Drivers

2.3.3 Idiopathic Hypersomnia Treatment Market Challenges

2.3.4 Idiopathic Hypersomnia Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Idiopathic Hypersomnia Treatment by Players

3.1.1 Global Idiopathic Hypersomnia Treatment Revenue by Players (2019-2024)

3.1.2 Global Idiopathic Hypersomnia Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Idiopathic Hypersomnia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Idiopathic Hypersomnia Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Idiopathic Hypersomnia Treatment Market Concentration Ratio

3.4.1 Global Idiopathic Hypersomnia Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Idiopathic Hypersomnia Treatment Revenue in 2023

3.5 Global Key Players of Idiopathic Hypersomnia Treatment Head office and Area Served

3.6 Global Key Players of Idiopathic Hypersomnia Treatment, Product and Application

3.7 Global Key Players of Idiopathic Hypersomnia Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Idiopathic Hypersomnia Treatment Breakdown Data by Type

4.1 Global Idiopathic Hypersomnia Treatment Historic Market Size by Type (2019-2024)

4.2 Global Idiopathic Hypersomnia Treatment Forecasted Market Size by Type (2025-2030)

5 Idiopathic Hypersomnia Treatment Breakdown Data by Application

5.1 Global Idiopathic Hypersomnia Treatment Historic Market Size by Application (2019-2024)

5.2 Global Idiopathic Hypersomnia Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Idiopathic Hypersomnia Treatment Market Size (2019-2030)

6.2 North America Idiopathic Hypersomnia Treatment Market Size by Type

6.2.1 North America Idiopathic Hypersomnia Treatment Market Size by Type (2019-2024)

6.2.2 North America Idiopathic Hypersomnia Treatment Market Size by Type (2025-2030)

6.2.3 North America Idiopathic Hypersomnia Treatment Market Share by Type (2019-2030)

6.3 North America Idiopathic Hypersomnia Treatment Market Size by Application

6.3.1 North America Idiopathic Hypersomnia Treatment Market Size by Application (2019-2024)

6.3.2 North America Idiopathic Hypersomnia Treatment Market Size by Application (2025-2030)

6.3.3 North America Idiopathic Hypersomnia Treatment Market Share by Application (2019-2030)

6.4 North America Idiopathic Hypersomnia Treatment Market Size by Country

6.4.1 North America Idiopathic Hypersomnia Treatment Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Idiopathic Hypersomnia Treatment Market Size by Country (2019-2024)

6.4.3 North America Idiopathic Hypersomnia Treatment Market Size by Country (2025-2030)

6.4.4 United States

6.4.5 Canada

7 Europe

7.1 Europe Idiopathic Hypersomnia Treatment Market Size (2019-2030)

7.2 Europe Idiopathic Hypersomnia Treatment Market Size by Type

7.2.1 Europe Idiopathic Hypersomnia Treatment Market Size by Type (2019-2024)

7.2.2 Europe Idiopathic Hypersomnia Treatment Market Size by Type (2025-2030)

7.2.3 Europe Idiopathic Hypersomnia Treatment Market Share by Type (2019-2030)

7.3 Europe Idiopathic Hypersomnia Treatment Market Size by Application

7.3.1 Europe Idiopathic Hypersomnia Treatment Market Size by Application (2019-2024)

7.3.2 Europe Idiopathic Hypersomnia Treatment Market Size by Application (2025-2030)

7.3.3 Europe Idiopathic Hypersomnia Treatment Market Share by Application (2019-2030)

7.4 Europe Idiopathic Hypersomnia Treatment Market Size by Country

7.4.1 Europe Idiopathic Hypersomnia Treatment Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Idiopathic Hypersomnia Treatment Market Size by Country (2019-2024)

7.4.3 Europe Idiopathic Hypersomnia Treatment Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Idiopathic Hypersomnia Treatment Market Size (2019-2030)

8.2 China Idiopathic Hypersomnia Treatment Market Size by Type

8.2.1 China Idiopathic Hypersomnia Treatment Market Size by Type (2019-2024)

8.2.2 China Idiopathic Hypersomnia Treatment Market Size by Type (2025-2030)

8.2.3 China Idiopathic Hypersomnia Treatment Market Share by Type (2019-2030)

8.3 China Idiopathic Hypersomnia Treatment Market Size by Application

8.3.1 China Idiopathic Hypersomnia Treatment Market Size by Application (2019-2024)

8.3.2 China Idiopathic Hypersomnia Treatment Market Size by Application (2025-2030)

8.3.3 China Idiopathic Hypersomnia Treatment Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Idiopathic Hypersomnia Treatment Market Size (2019-2030)

9.2 Asia Idiopathic Hypersomnia Treatment Market Size by Type

9.2.1 Asia Idiopathic Hypersomnia Treatment Market Size by Type (2019-2024)

9.2.2 Asia Idiopathic Hypersomnia Treatment Market Size by Type (2025-2030)

9.2.3 Asia Idiopathic Hypersomnia Treatment Market Share by Type (2019-2030)

9.3 Asia Idiopathic Hypersomnia Treatment Market Size by Application

9.3.1 Asia Idiopathic Hypersomnia Treatment Market Size by Application (2019-2024)

9.3.2 Asia Idiopathic Hypersomnia Treatment Market Size by Application (2025-2030)

9.3.3 Asia Idiopathic Hypersomnia Treatment Market Share by Application (2019-2030)

9.4 Asia Idiopathic Hypersomnia Treatment Market Size by Region

9.4.1 Asia Idiopathic Hypersomnia Treatment Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Idiopathic Hypersomnia Treatment Market Size by Region (2019-2024)

9.4.3 Asia Idiopathic Hypersomnia Treatment Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Type

10.2.1 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Application

10.3.1 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Country

10.4.1 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Takeda Pharmaceutical

11.1.1 Takeda Pharmaceutical Company Details

11.1.2 Takeda Pharmaceutical Business Overview

11.1.3 Takeda Pharmaceutical Idiopathic Hypersomnia Treatment Introduction

11.1.4 Takeda Pharmaceutical Revenue in Idiopathic Hypersomnia Treatment Business (2019-2024)

11.1.5 Takeda Pharmaceutical Recent Developments

11.2 Teva Pharmaceutical Industries

11.2.1 Teva Pharmaceutical Industries Company Details

11.2.2 Teva Pharmaceutical Industries Business Overview

11.2.3 Teva Pharmaceutical Industries Idiopathic Hypersomnia Treatment Introduction

11.2.4 Teva Pharmaceutical Industries Revenue in Idiopathic Hypersomnia Treatment Business (2019-2024)

11.2.5 Teva Pharmaceutical Industries Recent Developments

11.3 Jazz Pharmaceuticals

11.3.1 Jazz Pharmaceuticals Company Details

11.3.2 Jazz Pharmaceuticals Business Overview

11.3.3 Jazz Pharmaceuticals Idiopathic Hypersomnia Treatment Introduction

11.3.4 Jazz Pharmaceuticals Revenue in Idiopathic Hypersomnia Treatment Business (2019-2024)

11.3.5 Jazz Pharmaceuticals Recent Developments

11.4 BIOPROJET

11.4.1 BIOPROJET Company Details

11.4.2 BIOPROJET Business Overview

11.4.3 BIOPROJET Idiopathic Hypersomnia Treatment Introduction

11.4.4 BIOPROJET Revenue in Idiopathic Hypersomnia Treatment Business (2019-2024)

11.4.5 BIOPROJET Recent Developments

11.5 Avadel Pharmaceuticals

11.5.1 Avadel Pharmaceuticals Company Details

11.5.2 Avadel Pharmaceuticals Business Overview

11.5.3 Avadel Pharmaceuticals Idiopathic Hypersomnia Treatment Introduction

11.5.4 Avadel Pharmaceuticals Revenue in Idiopathic Hypersomnia Treatment Business (2019-2024)

11.5.5 Avadel Pharmaceuticals Recent Developments

11.6 GlaxoSmithKline

11.6.1 GlaxoSmithKline Company Details

11.6.2 GlaxoSmithKline Business Overview

11.6.3 GlaxoSmithKline Idiopathic Hypersomnia Treatment Introduction

11.6.4 GlaxoSmithKline Revenue in Idiopathic Hypersomnia Treatment Business (2019-2024)

11.6.5 GlaxoSmithKline Recent Developments

11.7 Pfizer

11.7.1 Pfizer Company Details

11.7.2 Pfizer Business Overview

11.7.3 Pfizer Idiopathic Hypersomnia Treatment Introduction

11.7.4 Pfizer Revenue in Idiopathic Hypersomnia Treatment Business (2019-2024)

11.7.5 Pfizer Recent Developments

11.8 Theranexus

11.8.1 Theranexus Company Details

11.8.2 Theranexus Business Overview

11.8.3 Theranexus Idiopathic Hypersomnia Treatment Introduction

11.8.4 Theranexus Revenue in Idiopathic Hypersomnia Treatment Business (2019-2024)

11.8.5 Theranexus Recent Developments

11.9 Fisher and Paykel Healthcare

11.9.1 Fisher and Paykel Healthcare Company Details

11.9.2 Fisher and Paykel Healthcare Business Overview

11.9.3 Fisher and Paykel Healthcare Idiopathic Hypersomnia Treatment Introduction

11.9.4 Fisher and Paykel Healthcare Revenue in Idiopathic Hypersomnia Treatment Business (2019-2024)

11.9.5 Fisher and Paykel Healthcare Recent Developments

11.10 Drive DeVilbiss Healthcare

11.10.1 Drive DeVilbiss Healthcare Company Details

11.10.2 Drive DeVilbiss Healthcare Business Overview

11.10.3 Drive DeVilbiss Healthcare Idiopathic Hypersomnia Treatment Introduction

11.10.4 Drive DeVilbiss Healthcare Revenue in Idiopathic Hypersomnia Treatment Business (2019-2024)

11.10.5 Drive DeVilbiss Healthcare Recent Developments

11.11 Merck

11.11.1 Merck Company Details

11.11.2 Merck Business Overview

11.11.3 Merck Idiopathic Hypersomnia Treatment Introduction

11.11.4 Merck Revenue in Idiopathic Hypersomnia Treatment Business (2019-2024)

11.11.5 Merck Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Takeda Pharmaceutical

Teva Pharmaceutical Industries

Jazz Pharmaceuticals

Bioprojet

Avadel Pharmaceuticals

GlaxoSmithKline PLC

Pfizer Inc

Theranexus

Fisher and Paykel Healthcare

Drive DeVilbiss Healthcare

Merck

List of Tables

Table 1. Global Idiopathic Hypersomnia Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Stimulant Medications

Table 3. Key Players of Non-Stimulant Wake-Promoting Medications

Table 4. Key Players of Sodium Oxybate

Table 5. Global Idiopathic Hypersomnia Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Idiopathic Hypersomnia Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Idiopathic Hypersomnia Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Idiopathic Hypersomnia Treatment Market Share by Region (2019-2024)

Table 9. Global Idiopathic Hypersomnia Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Idiopathic Hypersomnia Treatment Market Share by Region (2025-2030)

Table 11. Idiopathic Hypersomnia Treatment Market Trends

Table 12. Idiopathic Hypersomnia Treatment Market Drivers

Table 13. Idiopathic Hypersomnia Treatment Market Challenges

Table 14. Idiopathic Hypersomnia Treatment Market Restraints

Table 15. Global Idiopathic Hypersomnia Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Idiopathic Hypersomnia Treatment Revenue Share by Players (2019-2024)

Table 17. Global Top Idiopathic Hypersomnia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Idiopathic Hypersomnia Treatment as of 2023)

Table 18. Global Idiopathic Hypersomnia Treatment Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Idiopathic Hypersomnia Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Idiopathic Hypersomnia Treatment, Headquarters and Area Served

Table 21. Global Key Players of Idiopathic Hypersomnia Treatment, Product and Application

Table 22. Global Key Players of Idiopathic Hypersomnia Treatment, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Idiopathic Hypersomnia Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Idiopathic Hypersomnia Treatment Revenue Market Share by Type (2019-2024)

Table 26. Global Idiopathic Hypersomnia Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Idiopathic Hypersomnia Treatment Revenue Market Share by Type (2025-2030)

Table 28. Global Idiopathic Hypersomnia Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Idiopathic Hypersomnia Treatment Revenue Share by Application (2019-2024)

Table 30. Global Idiopathic Hypersomnia Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Idiopathic Hypersomnia Treatment Revenue Share by Application (2025-2030)

Table 32. North America Idiopathic Hypersomnia Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Idiopathic Hypersomnia Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Idiopathic Hypersomnia Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Idiopathic Hypersomnia Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Idiopathic Hypersomnia Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Idiopathic Hypersomnia Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Idiopathic Hypersomnia Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Idiopathic Hypersomnia Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Idiopathic Hypersomnia Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Idiopathic Hypersomnia Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Idiopathic Hypersomnia Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Idiopathic Hypersomnia Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Idiopathic Hypersomnia Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Idiopathic Hypersomnia Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Idiopathic Hypersomnia Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Idiopathic Hypersomnia Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Idiopathic Hypersomnia Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Idiopathic Hypersomnia Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Idiopathic Hypersomnia Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Idiopathic Hypersomnia Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Idiopathic Hypersomnia Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Idiopathic Hypersomnia Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Idiopathic Hypersomnia Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Idiopathic Hypersomnia Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Idiopathic Hypersomnia Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 64. Takeda Pharmaceutical Company Details

Table 65. Takeda Pharmaceutical Business Overview

Table 66. Takeda Pharmaceutical Idiopathic Hypersomnia Treatment Product

Table 67. Takeda Pharmaceutical Revenue in Idiopathic Hypersomnia Treatment Business (2019-2024) & (US$ Million)

Table 68. Takeda Pharmaceutical Recent Developments

Table 69. Teva Pharmaceutical Industries Company Details

Table 70. Teva Pharmaceutical Industries Business Overview

Table 71. Teva Pharmaceutical Industries Idiopathic Hypersomnia Treatment Product

Table 72. Teva Pharmaceutical Industries Revenue in Idiopathic Hypersomnia Treatment Business (2019-2024) & (US$ Million)

Table 73. Teva Pharmaceutical Industries Recent Developments

Table 74. Jazz Pharmaceuticals Company Details

Table 75. Jazz Pharmaceuticals Business Overview

Table 76. Jazz Pharmaceuticals Idiopathic Hypersomnia Treatment Product

Table 77. Jazz Pharmaceuticals Revenue in Idiopathic Hypersomnia Treatment Business (2019-2024) & (US$ Million)

Table 78. Jazz Pharmaceuticals Recent Developments

Table 79. BIOPROJET Company Details

Table 80. BIOPROJET Business Overview

Table 81. BIOPROJET Idiopathic Hypersomnia Treatment Product

Table 82. BIOPROJET Revenue in Idiopathic Hypersomnia Treatment Business (2019-2024) & (US$ Million)

Table 83. BIOPROJET Recent Developments

Table 84. Avadel Pharmaceuticals Company Details

Table 85. Avadel Pharmaceuticals Business Overview

Table 86. Avadel Pharmaceuticals Idiopathic Hypersomnia Treatment Product

Table 87. Avadel Pharmaceuticals Revenue in Idiopathic Hypersomnia Treatment Business (2019-2024) & (US$ Million)

Table 88. Avadel Pharmaceuticals Recent Developments

Table 89. GlaxoSmithKline Company Details

Table 90. GlaxoSmithKline Business Overview

Table 91. GlaxoSmithKline Idiopathic Hypersomnia Treatment Product

Table 92. GlaxoSmithKline Revenue in Idiopathic Hypersomnia Treatment Business (2019-2024) & (US$ Million)

Table 93. GlaxoSmithKline Recent Developments

Table 94. Pfizer Company Details

Table 95. Pfizer Business Overview

Table 96. Pfizer Idiopathic Hypersomnia Treatment Product

Table 97. Pfizer Revenue in Idiopathic Hypersomnia Treatment Business (2019-2024) & (US$ Million)

Table 98. Pfizer Recent Developments

Table 99. Theranexus Company Details

Table 100. Theranexus Business Overview

Table 101. Theranexus Idiopathic Hypersomnia Treatment Product

Table 102. Theranexus Revenue in Idiopathic Hypersomnia Treatment Business (2019-2024) & (US$ Million)

Table 103. Theranexus Recent Developments

Table 104. Fisher and Paykel Healthcare Company Details

Table 105. Fisher and Paykel Healthcare Business Overview

Table 106. Fisher and Paykel Healthcare Idiopathic Hypersomnia Treatment Product

Table 107. Fisher and Paykel Healthcare Revenue in Idiopathic Hypersomnia Treatment Business (2019-2024) & (US$ Million)

Table 108. Fisher and Paykel Healthcare Recent Developments

Table 109. Drive DeVilbiss Healthcare Company Details

Table 110. Drive DeVilbiss Healthcare Business Overview

Table 111. Drive DeVilbiss Healthcare Idiopathic Hypersomnia Treatment Product

Table 112. Drive DeVilbiss Healthcare Revenue in Idiopathic Hypersomnia Treatment Business (2019-2024) & (US$ Million)

Table 113. Drive DeVilbiss Healthcare Recent Developments

Table 114. Merck Company Details

Table 115. Merck Business Overview

Table 116. Merck Idiopathic Hypersomnia Treatment Product

Table 117. Merck Revenue in Idiopathic Hypersomnia Treatment Business (2019-2024) & (US$ Million)

Table 118. Merck Recent Developments

Table 119. Research Programs/Design for This Report

Table 120. Key Data Information from Secondary Sources

Table 121. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Idiopathic Hypersomnia Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Idiopathic Hypersomnia Treatment Market Share by Type: 2023 VS 2030

Figure 3. Stimulant Medications Features

Figure 4. Non-Stimulant Wake-Promoting Medications Features

Figure 5. Sodium Oxybate Features

Figure 6. Global Idiopathic Hypersomnia Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Idiopathic Hypersomnia Treatment Market Share by Application: 2023 VS 2030

Figure 8. Hospital Pharmacies Case Studies

Figure 9. Retail Pharmacies Case Studies

Figure 10. Online Pharmacies Case Studies

Figure 11. Idiopathic Hypersomnia Treatment Report Years Considered

Figure 12. Global Idiopathic Hypersomnia Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Idiopathic Hypersomnia Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Idiopathic Hypersomnia Treatment Market Share by Region: 2023 VS 2030

Figure 15. Global Idiopathic Hypersomnia Treatment Market Share by Players in 2023

Figure 16. Global Top Idiopathic Hypersomnia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Idiopathic Hypersomnia Treatment as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Idiopathic Hypersomnia Treatment Revenue in 2023

Figure 18. North America Idiopathic Hypersomnia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Idiopathic Hypersomnia Treatment Market Share by Type (2019-2030)

Figure 20. North America Idiopathic Hypersomnia Treatment Market Share by Application (2019-2030)

Figure 21. North America Idiopathic Hypersomnia Treatment Market Share by Country (2019-2030)

Figure 22. United States Idiopathic Hypersomnia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Idiopathic Hypersomnia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Idiopathic Hypersomnia Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 25. Europe Idiopathic Hypersomnia Treatment Market Share by Type (2019-2030)

Figure 26. Europe Idiopathic Hypersomnia Treatment Market Share by Application (2019-2030)

Figure 27. Europe Idiopathic Hypersomnia Treatment Market Share by Country (2019-2030)

Figure 28. Germany Idiopathic Hypersomnia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Idiopathic Hypersomnia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Idiopathic Hypersomnia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Idiopathic Hypersomnia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Idiopathic Hypersomnia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Idiopathic Hypersomnia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Idiopathic Hypersomnia Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 35. China Idiopathic Hypersomnia Treatment Market Share by Type (2019-2030)

Figure 36. China Idiopathic Hypersomnia Treatment Market Share by Application (2019-2030)

Figure 37. Asia Idiopathic Hypersomnia Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 38. Asia Idiopathic Hypersomnia Treatment Market Share by Type (2019-2030)

Figure 39. Asia Idiopathic Hypersomnia Treatment Market Share by Application (2019-2030)

Figure 40. Asia Idiopathic Hypersomnia Treatment Market Share by Region (2019-2030)

Figure 41. Japan Idiopathic Hypersomnia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Idiopathic Hypersomnia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Idiopathic Hypersomnia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Idiopathic Hypersomnia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Idiopathic Hypersomnia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Idiopathic Hypersomnia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Share by Country (2019-2030)

Figure 51. Brazil Idiopathic Hypersomnia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Idiopathic Hypersomnia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Idiopathic Hypersomnia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Idiopathic Hypersomnia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Idiopathic Hypersomnia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Idiopathic Hypersomnia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Takeda Pharmaceutical Revenue Growth Rate in Idiopathic Hypersomnia Treatment Business (2019-2024)

Figure 58. Teva Pharmaceutical Industries Revenue Growth Rate in Idiopathic Hypersomnia Treatment Business (2019-2024)

Figure 59. Jazz Pharmaceuticals Revenue Growth Rate in Idiopathic Hypersomnia Treatment Business (2019-2024)

Figure 60. BIOPROJET Revenue Growth Rate in Idiopathic Hypersomnia Treatment Business (2019-2024)

Figure 61. Avadel Pharmaceuticals Revenue Growth Rate in Idiopathic Hypersomnia Treatment Business (2019-2024)

Figure 62. GlaxoSmithKline Revenue Growth Rate in Idiopathic Hypersomnia Treatment Business (2019-2024)

Figure 63. Pfizer Revenue Growth Rate in Idiopathic Hypersomnia Treatment Business (2019-2024)

Figure 64. Theranexus Revenue Growth Rate in Idiopathic Hypersomnia Treatment Business (2019-2024)

Figure 65. Fisher and Paykel Healthcare Revenue Growth Rate in Idiopathic Hypersomnia Treatment Business (2019-2024)

Figure 66. Drive DeVilbiss Healthcare Revenue Growth Rate in Idiopathic Hypersomnia Treatment Business (2019-2024)

Figure 67. Merck Revenue Growth Rate in Idiopathic Hypersomnia Treatment Business (2019-2024)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-29Z3105

Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Global Circadian Rhythm Sleep Disorders Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-8J6206

Wed Sep 25 00:00:00 UTC 2024

Add to Cart

Global Idiopathic Hypersomnia Treatment Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-11F10124

Wed Sep 25 00:00:00 UTC 2024

Add to Cart

Global Non-Wearable Sleep Tracker Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2T9457

Wed Sep 25 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Idiopathic Hypersomnia Treatment Market Insights, Forecast to 2030

Published Date: September 2024

Report Code: QYRE-Auto-11F10124

Global Idiopathic Hypersomnia Treatment Market Insights, Forecast to 2030

FEATURED COMPANIES

Idiopathic Hypersomnia Treatment Market Size

Idiopathic Hypersomnia Treatment Market

Scope of Idiopathic Hypersomnia Treatment Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Idiopathic Hypersomnia Treatment Market report?

What are the Application segmentation covered in the Idiopathic Hypersomnia Treatment Market report?

What are the Type segmentation covered in the Idiopathic Hypersomnia Treatment Market report?

FEATURED COMPANIES

RELATED REPORTS